Avantor Inc (AVTR)
22.99
+0.02
(+0.09%)
USD |
NYSE |
Nov 07, 16:00
23.00
+0.01
(+0.04%)
Pre-Market: 20:00
Avantor Revenue (TTM): 6.820B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.820B |
| June 30, 2024 | 6.826B |
| March 31, 2024 | 6.867B |
| December 31, 2023 | 6.967B |
| September 30, 2023 | 7.039B |
| June 30, 2023 | 7.176B |
| March 31, 2023 | 7.342B |
| December 31, 2022 | 7.512B |
| September 30, 2022 | 7.625B |
| June 30, 2022 | 7.603B |
| March 31, 2022 | 7.551B |
| December 31, 2021 | 7.386B |
| Date | Value |
|---|---|
| September 30, 2021 | 7.269B |
| June 30, 2021 | 7.040B |
| March 31, 2021 | 6.660B |
| December 31, 2020 | 6.394B |
| September 30, 2020 | 6.127B |
| June 30, 2020 | 6.026B |
| March 31, 2020 | 6.079B |
| December 31, 2019 | 6.040B |
| September 30, 2019 | 5.990B |
| June 30, 2019 | 5.981B |
| March 31, 2019 | 5.926B |
| December 31, 2018 | 5.864B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.026B
Minimum
Jun 2020
7.625B
Maximum
Sep 2022
6.917B
Average
7.003B
Median
Revenue (TTM) Benchmarks
| Revvity Inc | 2.722B |
| Bruker Corp | 3.241B |
| Azenta Inc | 658.62M |
| Harvard Bioscience Inc | 101.12M |
| Bionano Genomics Inc | 36.58M |